The most discussed topic of the past two years has been Covid-19, and its testing remains a hot topic. Even today, 23% of adults are very worried about the coronavirus, according to a recent survey by Prosper Insights & Analytics.
Fortunately, this crisis has spurred exciting new innovations—from diagnostics to treatments, vaccines to telemedicine. Today, 36% of U.S. adults have used some form of telehealth, up from just 13% in April 2020, according to a recent survey by Prosper Insight & Analytics.
Opentrons is a laboratory automation company at the center of life sciences innovation. While few are familiar with the name, they have attracted funding from SoftBank and their technology has fueled multiple breakthroughs. They've been at the forefront of Covid-19 testing since day one, and were even the first to detect the Omicron variant in New York last December.
The experienced service team and strong production support team provide customers with worry-free order services.
简体中文
繁體中文
English
日本語
한국인
